Clover Health Investments Corporation (CLOV) rose on Friday morning, with the stock gaining 1.11% to 1.82 in pre-market trading. CLOV’s short-term technical score of 15 indicates that it has traded less bullish than 85% of the stocks on the market in the last month. In the healthcare plans industry, which ranks 13th out of 146 industries, CLOV ranks above 0% of stocks. Clover Health Investments Corp has fallen 32.33% over the past month, and he closed at $2.41 on Sept. 2. CLOV has an average analyst recommendation of Buy. The company’s average price target is $3.50.
Clover Health Investments Corp has a long-term technical rank of 66. This means that over the last 200 days of trading, the company has been in the top half of the stock, with 34% of the market scoring higher. In the healthcare plan industry, which ranks fourth on this metric, CLOV outperforms equities by 4%.
Important dates for CLOV investors:
-Clover Health Investments Corp expects to announce earnings on November 8, 2022. Over the past 12 months, the company has reported EPS of -$0.90. -At this time, no dividend date has been set for Clover Health Investments Corp. For the full Clover Health Investments Corp (CLOV) report, click here.
Stay up to date
Subscribe to our daily morning update newsletter so you never miss any market news, moves and more you need to know.